Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The Role Of PET Imaging For Predicting Treatment Failure In Primary Mediastinal B-Cell Lymphoma

Sarah J. Nagle, MD, Elise A. Chong, MD, Seble Chekol, MD, Nirav N. Shah, MD, Sunita D. Nasta, MD, Eli Glatstein, MD, John P. Plastaras, MD PhD, Drew Torigian, MD, Stephen J. Schuster, MD, Jakub Svoboda, MD

Blood (2013) 122 (21): 4302.

https://doi.org/10.1182/blood.V122.21.4302.4302

Published: 2013

Journal Articles

A Prospective Trial of Radiation Alone vs Combination Chemotherapy Alone for Early-Stage Hodgkin’s Disease: Implications of 25-Year Follow-Up to Current Combined Modality Therapy.

Dan L. Longo, Eli Glatstein, Patricia L. Duffey, Robert C. Young, Shelby Fiem, Elaine S. Jaffe, Kevin Camphausen, Wyndham Wilson, Vincent T. DeVita

Blood (2006) 108 (11): 98.

https://doi.org/10.1182/blood.V108.11.98.98

Published: 2006

Journal Articles

Prognostic Value of FDG-PET in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.

Jakub Svoboda, Rebecca Elstrom, Elise A. Chong, Charalambos Andreadis, Arnold Berkowitz, Selina M. Luger, David L. Porter, Sunita Nasta, Lisa H. Downs, Donald L. Siegel, Eli Glatstein, Abass Alavi, Edward A. Stadtmauer, Stephen J. Schuster

Blood (2005) 106 (11): 2090.

https://doi.org/10.1182/blood.V106.11.2090.2090

Published: 2005

Journal Articles

Second Autologous Stem Cell Transplant (ASCT) as Salvage Therapy for Relapsed Multiple Myeloma.

Rebecca L. Olin, MD, David L. Porter, MD, Selina M. Luger, MD, Stephen J. Schuster, MD, Donald Tsai, MD, PhD, Sunita Nasta, MD, Alexander Perl, MD, Alison W. Loren, MD, Steven Goldstein, MD, Eli Glatstein, MD, Donald L. Siegel, MD, PhD, Dan T. Vogl, MD, Patricia Mangan, CRNP, Kathleen Cunningham, RN, BSN, Edward A. Stadtmauer, MD

Blood (2005) 106 (11): 1170.

https://doi.org/10.1182/blood.V106.11.1170.1170

Published: 2005

Journal Articles

Thalidomide and Dexamethasone Induction Therapy Is Associated with Superior Progression-Free Survival after Autotransplant for Myeloma.

Dan T. Vogl, MD, Selina Luger, MD, David L. Porter, MD, Elise A. Chong, Stephen J. Schuster, MD, Donald E. Tsai, MD, Alexander Perl, MD, Alison W. Loren, MD, MS, Stephen Goldstein, MD, Sunita D. Nasta, MD, Charalambos Andreadis, MD, Patricia A. Mangan, Kimberly Hummel, Donald L. Siegel, MD, PhD, Eli Glatstein, MD, Edward A. Stadtmauer, MD

Blood (2005) 106 (11): 1171.

https://doi.org/10.1182/blood.V106.11.1171.1171

Published: 2005

NARROW

The Role Of PET Imaging For Predicting Treatment Failure In Primary Mediastinal B-Cell Lymphoma

A Prospective Trial of Radiation Alone vs Combination Chemotherapy Alone for Early-Stage Hodgkin’s Disease: Implications of 25-Year Follow-Up to Current Combined Modality Therapy.

Prognostic Value of FDG-PET in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.

Second Autologous Stem Cell Transplant (ASCT) as Salvage Therapy for Relapsed Multiple Myeloma.

Thalidomide and Dexamethasone Induction Therapy Is Associated with Superior Progression-Free Survival after Autotransplant for Myeloma.

Email alerts

ASH Publications

American Society of Hematology

The Role Of PET Imaging For Predicting Treatment Failure In Primary Mediastinal B-Cell Lymphoma

A Prospective Trial of Radiation Alone vs Combination Chemotherapy Alone for Early-Stage Hodgkin’s Disease: Implications of 25-Year Follow-Up to Current Combined Modality Therapy.

Prognostic Value of FDG-PET in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.

Second Autologous Stem Cell Transplant (ASCT) as Salvage Therapy for Relapsed Multiple Myeloma.

Thalidomide and Dexamethasone Induction Therapy Is Associated with Superior Progression-Free Survival after Autotransplant for Myeloma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only